Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Measurement of the severity related to cutaneous neurofibromas in neurofibromatosis type 1: development and validation of the Nef-ASI.
Measurement of the severity related to cutaneous neurofibromas in neurofibromatosis type 1: development and validation of the Nef-ASI. Journal of the American Academy of Dermatology Fertitta, L., Jannic, A., Bergqvist, C., Delique, V., Armand, M. L., Moryousef, S., Ferkal, S., Zehou, O., Ayache, H., Le Corvoisier, P., Audureau, E., Hebrard, B., Lunati-Rozie, A., Funalot, B., Sarin, K. Y., Blakeley, J. O., Romo, C. G., Berman, Y., Le, L. Q., Ezzedine, K., Wolkenstein, P. 2025View details for DOI 10.1016/j.jaad.2025.10.025
View details for PubMedID 41061983